Terri B. Sebree
President
Ms. Sebree is a co-founder of NuPathe. She most recently served as Senior Vice President, Development of Auxilium Pharmaceuticals, Inc. where she led the development effort which resulted in the approval of the company’s lead product within 22 months of the commencement of development. Prior to that, Ms. Sebree served as Executive Vice President of the US Operations of Omnicare Clinical Research (formerly IBAH/BioPharm), a large, multinational CRO, where she was responsible for the successful completion of dozens of clinical development programs. Ms. Sebree spent nine years at Abbott Laboratories where she served in positions of increasing responsibility, ultimately serving as Venture Head for psychopharmacology drug development. Ms. Sebree began her career in pharmaceutical drug development at Servier Laboratories, USA where she served in several positions in clinical research and quality assurance.
